Trademarkia Logo

Australia

AU$
Trademark Search
CX

View On IPO.GOV.AU

CX
Registered: Registered/protected

Last updated on 20 Oct 2022

Owner Info

CytomX Therapeutics, Inc.

151 Oyster Point Boulevard

Suite 400, South San Francisco, California, 94080 UNITED STATES OF AMERICA

Serial Number

2255550 filed on 11 Mar 2022

Correspondent

FB Rice Pty Ltd

Level 29,

126 Phillip Street,

Sydney, NSW, 2000 AUSTRALIA

CX

Classification Information

Class [001]
Biochemicals for scientific, research, industrial, and manufacturing use; Immunoglobulin and antigen-binding fragments, proteins, polypeptides, polyne Read More

Class [005]
Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; Pharmaceutical and biological preparations for immunot Read More

Mark Details

Serial Number

2255550

Registered On

11 Mar 2022

Renewal On

11 Mar 2032

Mark Type

FIGURATIVE

Legal History

Show more

Status DateAction Taken
20th Oct 2022IP Right Registered correspondence sent
19th Oct 2022IP Right Registration Published
19th Oct 2022Status change to Registered/Protected
12th Aug 2022Application Accepted correspondence sent
12th Aug 2022IP Right has been Examined
12th Aug 2022IP Right Acceptance Published
28th Apr 2022Early Acceptance Notice correspondence sent
28th Apr 2022Status change to Accepted
26th Apr 2022Customer Amendment Made correspondence sent
26th Apr 2022Owner name details updated